JP Morgan Chase’s GSK PLC ADRhedged GSKH Stock Holding History

JP Morgan Chase’s Portfolio GSKH Stock Details GSKH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$70	Hold	1	–	–	﹤0.01%	7866
2026 Q2	$74	Hold	1	–	–	﹤0.01%	7558
2026 Q1	$77	Buy	+1	New	+$76	﹤0.01%	7328

JP Morgan Chase's GSKH Position: Q3 2026 in Review

JP Morgan Chase held its GSK PLC ADRhedged (GSKH) position steady in Q3 2026 at 1 share worth $70. The position accounts for ﹤0.01% of the portfolio, ranked #7866.

JP Morgan Chase first reported a position in GSKH in Q1 2026 and has held it in 3 quarters since. The position peaked at $77 in Q1 2026. 1 fund tracked by Wall St. Rank holds GSKH as of Q3 2026.

JP Morgan Chase held 1 share of GSK PLC ADRhedged worth $70 as of Q3 2026.
JP Morgan Chase left its GSK PLC ADRhedged share count unchanged in Q3 2026.
GSK PLC ADRhedged made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7866 holding.
JP Morgan Chase first reported a position in GSK PLC ADRhedged in Q1 2026 and has held it in 3 quarters since.
JP Morgan Chase's GSK PLC ADRhedged position peaked at $77 in Q1 2026.
1 fund tracked by Wall St. Rank held GSK PLC ADRhedged as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.